Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.150
+0.040 (1.90%)
Dec 5, 2025, 4:00 PM EST - Market closed
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $98.59 million as of December 5, 2025. Its market cap has increased by 61.25% in one year.
Market Cap
98.59M
Enterprise Value
90.23M
1-Year Change
61.25%
Ranking
Category
Stock Price
$2.15
Market Cap Chart
Since June 28, 2018, Entera Bio's market cap has increased from $71.77M to $98.59M, an increase of 37.37%. That is a compound annual growth rate of 4.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 96.76M | 23.92% |
| Dec 31, 2024 | 78.08M | 351.66% |
| Dec 29, 2023 | 17.29M | -17.80% |
| Dec 30, 2022 | 21.03M | -74.04% |
| Dec 31, 2021 | 81.03M | 308.59% |
| Dec 31, 2020 | 19.83M | -23.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |